Search
Advanced Search

For The Correct Development Of The Phase I Open Clinical Trial To Evaluate The Safety And Preliminary Clinical Response Of The Use Of Allogeneic Mesenchymal Stem Cells From Bone Marrow In Children And Adolescents With X-Linked Adrenoleukodystrophy, Cerebral Form

pp

General Information
   Oct 18, 2024
   Spanish
   Other
40000 EUR
   published: Oct 18, 2024

Original Text

001/2024Para el correcto desarrollo del Ensayo Clínico Abierto fase I para evaluar la seguridad y respuesta clínica preliminar del uso de células madre mesenquimales alogénicas de médula ósea en niños y adolescentes con adrenoleucodistrofia ligada al cromosoma X forma cerebralServiciosResuelta40,000.0007/08/2024Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño...
Subscription Options

Basic

Full

Corporate

$550/year

$1000/year

Price on request

Buy Buy Contact Us
Please note that this notice is for your information only.
We try our best to have the most accurate and up-to-date information available on our web site, but we cannot guarantee that all of the information provided is error-free.
If you have any suggestions for updates/corrections for this notice, please let us know.